These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12117681)

  • 1. Serum interleukin 18 and interleukin 18 binding protein in rheumatoid arthritis.
    Bresnihan B; Roux-Lombard P; Murphy E; Kane D; FitzGerald O; Dayer JM
    Ann Rheum Dis; 2002 Aug; 61(8):726-9. PubMed ID: 12117681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
    Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
    Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13.
    Pittoni V; Bombardieri M; Spinelli FR; Scrivo R; Alessandri C; Conti F; Spadaro A; Valesini G
    Ann Rheum Dis; 2002 Aug; 61(8):723-5. PubMed ID: 12117680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting interleukin 18 with interleukin 18 binding protein.
    Dinarello CA
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i17-20. PubMed ID: 11053080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raised circulating tenascin-C in rheumatoid arthritis.
    Page TH; Charles PJ; Piccinini AM; Nicolaidou V; Taylor PC; Midwood KS
    Arthritis Res Ther; 2012 Nov; 14(6):R260. PubMed ID: 23193984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 18 and interleukin 18 binding protein in patients with idiopathic thrombocytopenic purpura.
    Shan NN; Zhu XJ; Peng J; Qin P; Zhuang XW; Wang HC; Hou M
    Br J Haematol; 2009 Mar; 144(5):755-61. PubMed ID: 19077159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
    Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
    Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis.
    Kane D; Roth J; Frosch M; Vogl T; Bresnihan B; FitzGerald O
    Arthritis Rheum; 2003 Jun; 48(6):1676-85. PubMed ID: 12794836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy.
    Visvanathan S; Wagner C; Rojas J; Kay J; Dasgupta B; Matteson EL; Mack M; Baker DG; Rahman MU
    J Rheumatol; 2009 Jul; 36(7):1371-9. PubMed ID: 19487269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum hyaluronan in psoriatic arthritis patients in comparison to rheumatoid arthritis patients.
    Partsch G; Leeb B; Stancikova M; Raffayova H; Eberl G; Hitzelhammer H; Smolen JS
    Clin Exp Rheumatol; 1996; 14(4):381-6. PubMed ID: 8871836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.
    Ramírez J; Inciarte-Mundo J; Cuervo A; Ruiz-Esquide V; Hernández MV; Sanmartí R; Cañete JD
    Clin Exp Rheumatol; 2017; 35(1):74-79. PubMed ID: 27749227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis.
    Rooney T; Murphy E; Benito M; Roux-Lombard P; FitzGerald O; Dayer JM; Bresnihan B
    Ann Rheum Dis; 2004 Nov; 63(11):1393-8. PubMed ID: 15479888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anti-rheumatic treatment on selenium levels in inflammatory arthritis.
    Deyab G; Hokstad I; Aaseth J; Småstuen MC; Whist JE; Agewall S; Lyberg T; Tveiten D; Hjeltnes G; Zibara K; Hollan I
    J Trace Elem Med Biol; 2018 Sep; 49():91-97. PubMed ID: 29895378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel targets for interleukin 18 binding protein.
    Dinarello CA
    Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii18-24. PubMed ID: 11890646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.
    Ziolkowska M; Kurowska M; Radzikowska A; Luszczykiewicz G; Wiland P; Dziewczopolski W; Filipowicz-Sosnowska A; Pazdur J; Szechinski J; Kowalczewski J; Rell-Bakalarska M; Maslinski W
    Arthritis Rheum; 2002 Jul; 46(7):1744-53. PubMed ID: 12124857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum calprotectin as a marker of ultrasound-detected synovitis in early psoriatic and rheumatoid arthritis: results from a cross-sectional retrospective study.
    Sakellariou G; Lombardi G; Vitolo B; Gomarasca M; Faraldi M; Caporali R; Banfi G; Montecucco C
    Clin Exp Rheumatol; 2019; 37(3):429-436. PubMed ID: 30299248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis.
    Murota A; Suzuki K; Kassai Y; Miyazaki T; Morita R; Kondo Y; Takeshita M; Niki Y; Yoshimura A; Takeuchi T
    Cytokine; 2016 Feb; 78():87-93. PubMed ID: 26700586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
    Ballara S; Taylor PC; Reusch P; Marmé D; Feldmann M; Maini RN; Paleolog EM
    Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
    Heiberg MS; Koldingsnes W; Mikkelsen K; Rødevand E; Kaufmann C; Mowinckel P; Kvien TK
    Arthritis Rheum; 2008 Feb; 59(2):234-40. PubMed ID: 18240258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.